Feasibility, safety, and early outcomes of direct carotid artery stent implantation with use of the FilterWire EZ™ Embolic Protection System

Josef Veselka(Universitat Autònoma de Barcelona), Radka Duchoňová(University Hospital in Motol), Petra Zimolová(University Hospital in Motol), Martin Malý(Charles University), Jiří Fiedler(Charles University), Lucie Martinkovičová(Charles University), David Zemánek, Daniela Černá(University Hospital in Motol), Petr Hájek(University Hospital in Motol)
Catheterization and Cardiovascular Interventions
December 19, 2008
10.1002/ccd.21936
Cited by 20

Related Papers

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest
|JAMA|2022|674
Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS
|Catheterization and Cardiovascular Interventions|2009|190
Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population
|European Heart Journal|2014|106
A FTO variant and risk of acute coronary syndrome
|Clinica Chimica Acta|2010|65